S&P 500 Technology Sector SEC Filings — March 04, 2026

04-03-2026

Texas Instruments Incorporated (TXN) filed Definitive Additional Proxy Materials (DEFA14A) on March 04, 2026, pursuant to Section 14(a) of the Securities Exchange Act of 1934. The filing indicates no fee was required. No substantive financial or operational details are provided in the available content.

04-03-2026

This DEF 14A proxy statement solicits shareholder votes for the election of board members at the virtual annual meeting on April 16, 2026, for Nuveen Virginia Quality Municipal Income Fund (NPV) and 15 other Nuveen funds. For NPV, holders of Common and Preferred Shares vote together to elect four Class II Board Members, while Preferred Share holders vote separately to elect two Board Members. The record date is February 9, 2026, with no financial performance metrics disclosed.

• ·Annual Meeting: April 16, 2026, at 2:00 p.m. Central Time, virtual only via meetnow.global/M6VY4FD
• ·Record date: February 9, 2026
• ·Proxy materials mailed on or about March 6, 2026
• ·Quorum: Majority of shares for most votes; 33 1/3% of Preferred Shares for their separate election
• ·Registration for virtual attendance required 3 business days prior if held by intermediary

04-03-2026

Nuveen Quality Municipal Income Fund extended the final mandatory redemption date for its Series 1 Variable Rate Demand Preferred Shares ($236.8M aggregate liquidation preference) and Series 2 Variable Rate Demand Preferred Shares ($267.5M aggregate liquidation preference) from September 11, 2026, to September 11, 2056, effective March 3, 2026. This extension applies to these senior securities, which rank ahead of common shares (NAD) in liquidation and dividends, with weekly dividend rates set by a remarketing agent and liquidity support from a provider. No performance declines or flat metrics were reported in this disclosure.

• ·Dividends on VRDPs set weekly by remarketing agent, subject to maximum rate that increases during extended unsuccessful remarketing.
• ·Liquidity feature allows holders to sell to liquidity provider if remarketing fails.
• ·VRDPs not registered under Securities Act of 1933; disclosure not an offer to sell.

04-03-2026

ImmuCell Corporation reported 2025 product sales of $27.6 million, up 4.3% YoY from $26.5 million, with gross margin expanding to 41.4% from 30% due to higher volumes (380,000 units/month vs. 345,000) and efficiencies, resulting in net operating income of $1.6 million versus a $1.6 million loss in 2024. However, the company posted a net loss of $1.0 million, improved from $2.2 million but driven by one-time charges including a $2.7 million Re-Tain asset write-down, $651,000 colostrum inventory write-down, and $297,000 CEO transition expenses; Q4 saw a net loss of $2.8 million versus a $0.5 million profit. Balance sheet showed stable cash at $3.8 million but a slight decline in stockholders' equity to $27.1 million from $27.5 million.

• ·EBITDA for 2025 was $2.2 million vs. $1.1 million in 2024.
• ·Cash from operating activities improved to $2.5 million in 2025 from $0.4 million in 2024.
• ·Total assets decreased to $42.5 million as of Dec 31, 2025 from $45.1 million as of Dec 31, 2024.
• ·Conference call scheduled for March 5, 2026 at 9:00 AM ET.

04-03-2026

NCS Multistage Holdings, Inc. filed a Form 8-K on 2026-03-04 disclosing results of operations and financial condition under Item 2.02, accompanied by financial statements and exhibits under Item 9.01. No specific quantitative financial metrics such as revenue, earnings, margins, or period-over-period comparisons are mentioned in the provided filing details. This appears to be a standard voluntary earnings-related disclosure with no detailed performance data available.

04-03-2026

Broadcom Inc. reported record Q1 FY2026 revenue of $19.3B, up 29% YoY, driven by 52% growth in Semiconductor solutions to $12.5B and 106% YoY increase in AI revenue to $8.4B; however, Infrastructure software grew only 1% YoY to $6.8B. GAAP net income rose 34% YoY to $7.3B but declined 14% QoQ from $8.5B, while Adjusted EBITDA hit $13.1B (+30% YoY, 68% margin). Q2 guidance projects $22.0B revenue (+47% YoY) at 68% Adjusted EBITDA margin, alongside a $0.65/share dividend and new $10B share repurchase program through Dec 31, 2026.

• ·Cash and equivalents decreased to $14.2B from $16.2B prior quarter.
• ·Q1 stock-based compensation expense totaled $2,176M.
• ·Dividend payable March 31, 2026 to shareholders of record March 23, 2026.

04-03-2026

A Paradise Acquisition Corp., a SPAC, is pursuing a business combination with Enhanced Ltd, an unproven company with limited operating history and minimal revenue to date, planning to file a Form S-4 registration statement with the SEC. The presentation introduces Enhanced's executive team with pedigrees from organizations like the United States Olympic Committee and Barstool Sports, while highlighting initiatives like the inaugural 2026 Enhanced Games. However, it emphasizes substantial risks including regulatory scrutiny, failure to secure approvals, ethical concerns over performance-enhancement, and dependence on key personnel and financing.

• ·A Paradise IPO prospectus dated July 29, 2025.
• ·Form S-4 registration statement to be filed with SEC, including proxy statement/prospectus.
• ·Contact: The Sun’s Group Center, 29th Floor, 200 Gloucester Road, Wan Chai, Hong Kong; +852 9583 3199.